The Biden-Harris administration announced Monday a new requirement for insurance providers to cover injectable PrEP in their ...
Long-acting injectable PrEP is now to be covered without cost-sharing under Affordable Care Act rules, the Biden ...
PrEP use increased between 2013 and 2023, according to a research letter published online in the Journal of the American Medical Association.
Learn about the changing trend in pre exposure prophylaxis medication prescription for HIV patients in the US over the past ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Gilead Sciences’s decision to distribute HIV prevention drug lenacapavir made the news this month when they signed ...
Affordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
Following injectable cabotegravir availability in 2022, prescriptions increased from 1.1% in 2022 to 2.5% in 2023. “New PrEP medications are heavily marketed, yet, generic PrEP dominated the ...
About The Study: Preexposure prophylaxis (PrEP) use increased between 2013 and 2023, with generic tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) being the most frequently prescribed ...